CRBP

Roll Forward 2 Covered Calls on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 27.39% in 190 days

On January 19, 2021, we roll forwarded 2 covered calls on CRBP stock with expiry on March 19, 2021. For this trade, we got a small $35.2 premium (after commissions). This trade…

Covered Call on Call on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 16.93% in 226 days (27.27% annualized)

On October 19, 2020, we sold 1 covered call on CRBP stock expiring on April 16, 2021. For this trade, we got a $10 premium (before commissions). CRBP - a clinical-stage drug…

Roll Forward Covered Call on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 28.2% in 232 days (44.27% annualized)

On October 19, 2020, we roll forwarded 1 covered call on CRBP stock with expiry on April 16, 2020. For this trade, we got a small $7.6 premium (after commissions). This trade was…

Roll Forward 2 Covered Calls on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 20.24% in 127 days (58.08% annualized)

On October 19, 2020, we roll forwarded 2 covered calls on CRBP stock with expiry on January 15, 2020. For this trade, we got a small $11.2 premium (after commissions). This trade…

September 2020 Options Income Report - $715.35

Here at OptionsBrew.com, we believe transparency is the key to success and that's why we have decided to share our monthly options income reports covering details behind the…

Trading plan for October 2020 (Option trades & Stock Buys)

Here at OptionsBrew.com, we believe a trading plan is already a 68% key to success. Without further ado, here is our trade plan for the upcoming month of October 2020. We are…

Roll Forward 2 Covered Calls on CRBP - Potential income return 18.15% in 35 days (189.12% annualized)

On September 21, 2020, we roll forwarded 2 covered calls on CRBP stock with expiry on October 16, 2020. For this trade, we got a $45.2 premium (after commissions). Corbus…

Covered Call on CRBP - Potential income return 63.21% in 50 days

On September 14, 2020, we sold 1 covered call on CRBP stock expiring on October 16, 2020. For this trade, we got a $25 premium (before commissions). CRBP - a clinical-stage drug…

Covered Call on CRBP - Potential income return 9.04% in 8 days

On September 10, 2020, we sold 2 covered calls on CRBP stock expiring on September 18, 2020. For this trade, we got a $43.2 premium (after commissions). Corbus Pharmaceuticals…

Update on CRBP Credit Spreads after stock falls more than 70%

Corbus Pharmaceuticals (NASDAQ:CRBP) dropped more than 70% on September 8, 2020, in reaction to an unsuccessful Phase 3 clinical trial, RESOLVE-1, evaluating lead drug lenabasum…

Credit Spread on CRBP – 8.64% potential return in 44 days

On September 2, 2020, we sold a bull put credit spread on CRBP stock with options expiry set in the next 44 days. CRBP  - Corbus Pharmaceuticals Holdings, Inc. is a Phase 3…

Credit Spread on CRBP – 5.7% potential return in 22 days

On August 27, 2020, we sold a bull put credit spread on CRBP stock with options expiry set in the next 30 days. CRBP  - Corbus Pharmaceuticals Holdings, Inc. is a Phase 3…